###### 

Number of patients with treatment emergent NRTI, NNRTI or PI resistance mutations

                             NRTI or PI Resistance mutations   
  -------------------------- --------------------------------- -------
  **LPV/r trials**                                             
  OK-04 (n=200, 96 wks)      2/100                             2/98
  Kalmo (n=60, 96 wks)       0/30                              0/30
  Kalesolo (n=186, 48 wks)   0/87                              0/99
  KRETA (n=88, 48 wks)       1/44                              0/44
  MOST (n=60, 24 wks)        0/29                              0/31
  DREAM (n=197, 96 wks)      3/11                              
  **DRV/r trials**                                             
  MONET (n=256, 144 wks)     1/127                             1/129
  MONOI (n=246, 96 wks)      0/112                             0/113
  Monarch (n=30, 48 wks)     0/15                              0/15
  PROTEA (n=273, 48 wks)     0/137                             0/136
  **Mixed PI trials**                                          
  PIVOT (n=587, 5 years)     7/291                             4/296
